Brazil Covaxin Deal
-
{
- All
- News
- Videos
-
Brazil Contradicts Bharat Biotech Claim On Emergency Approval For Covaxin
- Monday July 5, 2021
- India News | Written by Uma Sudhir, Edited by Chandrashekar Srinivasan
Controversy over a $324 million deal between Brazil and Bharat Biotech - for the import of 20 million Covaxin doses - continues to grow, with reports from the South American country saying its national health regulator never gave the vaccine an EUA.
-
www.ndtv.com
-
Thousands In Brazil Join Anti-Bolsonaro Protests Over Covaxin Deal
- Sunday July 4, 2021
- India News | Agence France-Presse
Thousands of Brazilians took to the streets Saturday to protest against President Jair Bolsonaro, who faces an investigation over an allegedly corrupt Covid vaccine deal.
-
www.ndtv.com
-
Bharat Biotech Says 'No Wrongdoing' Amid Row Over Brazil Covaxin Deal
- Wednesday June 30, 2021
- India News | Edited by Deepshikha Ghosh
Bharat Biotech has denied any wrongdoing amid a huge controversy in Brazil over a $324 million contract for Covaxin, now suspended over allegations of irregularities that have singed the country's top leadership including President Jair Bolsanaro.
-
www.ndtv.com
-
Brazil Contradicts Bharat Biotech Claim On Emergency Approval For Covaxin
- Monday July 5, 2021
- India News | Written by Uma Sudhir, Edited by Chandrashekar Srinivasan
Controversy over a $324 million deal between Brazil and Bharat Biotech - for the import of 20 million Covaxin doses - continues to grow, with reports from the South American country saying its national health regulator never gave the vaccine an EUA.
-
www.ndtv.com
-
Thousands In Brazil Join Anti-Bolsonaro Protests Over Covaxin Deal
- Sunday July 4, 2021
- India News | Agence France-Presse
Thousands of Brazilians took to the streets Saturday to protest against President Jair Bolsonaro, who faces an investigation over an allegedly corrupt Covid vaccine deal.
-
www.ndtv.com
-
Bharat Biotech Says 'No Wrongdoing' Amid Row Over Brazil Covaxin Deal
- Wednesday June 30, 2021
- India News | Edited by Deepshikha Ghosh
Bharat Biotech has denied any wrongdoing amid a huge controversy in Brazil over a $324 million contract for Covaxin, now suspended over allegations of irregularities that have singed the country's top leadership including President Jair Bolsanaro.
-
www.ndtv.com